sb 216763 and xav939
sb 216763 has been researched along with xav939 in 3 studies
Compound Research Comparison
| Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (xav939) | Trials (xav939) | Recent Studies (post-2010) (xav939) |
|---|---|---|---|---|---|
| 342 | 0 | 225 | 186 | 0 | 179 |
Protein Interaction Comparison
| Protein | Taxonomy | sb 216763 (IC50) | xav939 (IC50) |
|---|---|---|---|
| Chain A, Tankyrase-1 | Homo sapiens (human) | 0.011 | |
| Chain A, Tankyrase-1 | Homo sapiens (human) | 0.011 | |
| Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | 0.0656 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.9968 | |
| Protein Wnt-3a | Mus musculus (house mouse) | 0.078 | |
| Protein Wnt-3a | Homo sapiens (human) | 0.078 | |
| Protein mono-ADP-ribosyltransferase PARP14 | Homo sapiens (human) | 5.8942 | |
| Vesicular acetylcholine transporter | Rattus norvegicus (Norway rat) | 0.015 | |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | 0.052 | |
| Poly [ADP-ribose] polymerase 2 | Homo sapiens (human) | 0.0792 | |
| Protein mono-ADP-ribosyltransferase PARP4 | Homo sapiens (human) | 4.3776 | |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | 0.8354 |
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Baharvand, H; Esfandiari, F; Fathi, A; Gourabi, H; Kiani, S; Nemati, S | 1 |
| Brooks, MM; Cammarata, PR; Neelam, S | 1 |
| Czogalla, B; Fraungruber, P; Heidegger, H; Jeschke, U; Kaltofen, T; Mahner, S; Mayr, D; Preinfalk, V; Schwertler, S; Trillsch, F; Vattai, A; Vilsmaier, T | 1 |
Other Studies
3 other study(ies) available for sb 216763 and xav939
| Article | Year |
|---|---|
Glycogen synthase kinase-3 inhibition promotes proliferation and neuronal differentiation of human-induced pluripotent stem cell-derived neural progenitors.
Topics: Basic Helix-Loop-Helix Transcription Factors; beta Catenin; Cell Differentiation; Cell Proliferation; Culture Media; Cyclin D1; Dipeptides; Epidermal Growth Factor; Fibroblast Growth Factor 2; Flow Cytometry; Fluorescent Antibody Technique; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 3-Ring; Homeodomain Proteins; Humans; Indoles; Induced Pluripotent Stem Cells; Maleimides; Neural Stem Cells; Neurogenesis; Proto-Oncogene Proteins c-myc; Pyridines; Pyrimidines; Receptors, Notch; Repressor Proteins; Signal Transduction; Time Factors; Transcription Factor HES-1 | 2012 |
Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
Topics: Animals; beta Catenin; Cattle; Cell Hypoxia; Cell Line; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Lens, Crystalline; Maleimides; Membrane Potential, Mitochondrial; Models, Biological; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Vascular Endothelial Growth Factor A | 2014 |
Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Cadherins; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Heterocyclic Compounds, 3-Ring; Humans; Indoles; Maleimides; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phenanthrenes; Wnt Signaling Pathway | 2020 |